France · Source-listed medicine information

France / CIS 64743130

AMINOSTAB, solution injectable pour perfusion en flacon

solution pour perfusion · intraveineuse

Directory source checks passedOriginal source language: French

Source data retrieved: 2026-09-17. Clinical review is not yet available.

Formsolution pour perfusion
Routeintraveineuse
Ingredient entries20
CountryFrance

Product identity

At a glance

Authorisation holder
FRESENIUS KABI FRANCE
Authorisation status
Autorisation active
Market status
Commercialisée
Country
France
Source reference
CIS 64743130

Reported market status does not confirm current pharmacy stock.

From the official composition record

Ingredients & strength

Source entries are shown individually. An active substance (SA) and its reference moiety (FT) may describe the same ingredient; do not add their strengths together.

Source composition entries for AMINOSTAB, solution injectable pour perfusion en flacon
IngredientStrength / referenceSource role
ASPARTIQUE (ACIDE)solution340 mgun flaconSAGroup 3
ALANINEsolution1600 mgun flaconSAGroup 1
LYSINE (ACÉTATE DE)solution1270 mgun flaconSAGroup 11
CYSTÉINEsolutionqsp 56 mgun flaconSAGroup 4
HISTIDINEsolution680 mgun flaconSAGroup 8
ISOLEUCINEsolution560 mgun flaconSAGroup 9
LEUCINEsolution790 mgun flaconSAGroup 10
LYSINEsolution900 mgun flaconFTGroup 11
PHÉNYLALANINEsolution790 mgun flaconSAGroup 13
SÉRINEsolution450 mgun flaconSAGroup 15
THRÉONINEsolution560 mgun flaconSAGroup 16
TRYPTOPHANE Lsolution190 mgun flaconSAGroup 17
VALINEsolution730 mgun flaconSAGroup 19
GLYCINEsolution790 mgun flaconSAGroup 7
GLUTAMIQUE (ACIDE)solution560 mgun flaconSAGroup 6
ARGININEsolution1130 mgun flaconSAGroup 2
MÉTHIONINEsolution560 mgun flaconSAGroup 12
PROLINEsolution680 mgun flaconSAGroup 14
TYROSINEsolution23 mgun flaconSAGroup 18
L-CYSTINEsolutionqsp 56 mgun flaconSAGroup 5

Pack references

Presentations (1)

1 flacon(s) en verre de 500 ml

CIP13 3400955695264

Présentation active · Déclaration de commercialisation

From the French medicines authority

Official documents

The official product entry provides access to the patient leaflet and professional product information when available. Documents are in French and availability varies by medicine.

Open the official product entryBDPM · CIS 64743130 · Opens in a new tab

Check the medicine name, strength and form against your pack. The authority’s current documents may be newer than the catalogue snapshot shown here.

Where this information comes from

Sources & dates

Base de données publique des médicaments (BDPM), France. Retrieval dates record when we obtained the source files; they are not clinical review dates or a guarantee of current stock.

Source files and their retrieval dates
Source fileRetrievedSource file modified
fr_products.txtNot supplied
fr_composition.txtNot supplied
fr_packs.txtNot supplied

Directory source checks cover the factual catalogue record.Molindra clinical guidance has not yet been reviewed or published for this medicine.

Our sources and review process →